Courtright P, Lewallen S, Tungpakorn N, Cho B H, Lim Y K, Lee H J, Kim S H
British Columbia Centre for Epidemiologic and International Ophthalmology, University of British Columbia, Vancouver, BC, Canada.
Br J Ophthalmol. 2001 Jun;85(6):643-7. doi: 10.1136/bjo.85.6.643.
BACKGROUND/AIMS: Cataract is the leading cause of blindness in leprosy patients. There is no population based information on the cataract surgical coverage, barriers to use of surgical services, and outcome of surgery in these patients. We sought to determine these measures of cataract programme effectiveness in a cured leprosy population in South Korea.
The population consisted of residents of six leprosy resettlement villages in central South Korea. All residents were invited to participate in a study of eye disease and interviewed regarding use of surgical services and reasons for not using these services.
The cataract surgical coverage in this population was 55.4% when <6/18 was used as the cut off and increased to 78.3% when the cut off was <6/60. Barriers reported by patients included being told by the doctor that the cataract was not mature and a perception by the patient that there was no need for surgery. Among patients who had aphakic surgery, 71% were still blind in the operative eye while among patients who had pseudophakic surgery, 14% were still blind (presenting vision). Blindness in pseudophakic patients could be reduced to 3% with spectacle correction.
Cataract prevalence in leprosy patients will increase as life expectancy continues to increase. Leprosy control programmes will need to develop activities aimed at reducing the burden of cataract. Recommendations include establishing collaborative agreements with ophthalmological services to provide high quality IOL surgery to these patients, training of health staff to identify and refer patients in need of surgery, monitoring the uptake of cataract surgery among patients needing services, and monitoring the outcome of surgery to improve refractive outcome.
背景/目的:白内障是麻风病患者失明的主要原因。目前尚无基于人群的关于白内障手术覆盖率、手术服务使用障碍以及这些患者手术效果的信息。我们试图在韩国已治愈的麻风病患者群体中确定白内障防治项目效果的这些指标。
研究人群包括韩国中部六个麻风病安置村的居民。邀请所有居民参与眼部疾病研究,并就手术服务的使用情况及未使用这些服务的原因进行访谈。
当以视力<6/18作为标准时,该人群的白内障手术覆盖率为55.4%;当标准变为<6/60时,覆盖率增至78.3%。患者报告的障碍包括医生告知白内障未成熟以及患者认为无需手术。在接受无晶状体手术的患者中,71%的术眼仍失明;而在接受人工晶状体植入手术的患者中,14%仍失明(当前视力)。通过配镜矫正,人工晶状体植入患者的失明率可降至3%。
随着预期寿命的持续增加,麻风病患者中的白内障患病率将会上升。麻风病防治项目需要开展旨在减轻白内障负担的活动。建议包括与眼科服务机构达成合作协议,为这些患者提供高质量的人工晶状体植入手术;培训医护人员识别并转诊需要手术的患者;监测需要服务的患者中白内障手术的接受情况;以及监测手术效果以改善屈光结果。